Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

• Main Authors: Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, Marco Lupidi, Aude Couturier, Voraporn Chaikitmongkol, Ermete Giancipoli, Patricio J. Rodríguez-Valdés, Pierre Henry Gabrielle, Inês Laíns, Ana Rita Santos, Zafer Cebeci, Atchara Amphornphruet, Valentin Degenhardt, Jan Darius Unterlauft, Carlo Cagini, Valérie Mané-Tauty, Giuseppe D’Amico Ricci, Isaac Hindi, Kushal Agrawal, Jay Chhablani, Anat Loewenstein, Dinah Zur, Matus Rehak
• Format: Journal
• Published: 2020
• Subjects: Biochemistry, Genetics and Molecular Biology; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074074965&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/67601
• Institution: Chiang Mai University

© 2019, Springer-Verlag Italia S.r.l., part of Springer Nature. Aims: To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under...